Search - tctmd.com

Displaying 301 - 320 of 2151

Sort: Relevancy | Date

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

Presentation TCT 2019

The Future in Managing Patients at High Bleeding Risk

Presenter: Elvin Kedhi

September 26, 2019

Presentation TCT 2019

Two Case Presentations Highlighting Relevant Patients

Presenter: David Kandzari

September 26, 2019

Presentation TCT 2019

Onyx One: Results and Implications

Presenter: Azeem Latib

September 26, 2019

Presentation TCT 2019

Why Onyx One?

Presenter: Ajay Kirtane

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

Presentation TCT 2019

Who is the High Bleeding Risk Patient?

Presenter: Daniel Simon

September 26, 2019

Presentation TCT 2019

Emerging Drug-Free Platforms for the SFA: Can We Do Better Off Drugs?

Presenter: William Gray

September 26, 2019

Presentation TCT 2019

Circumstances in Which I Feel That I Have to Use DCB/DES

Presenter: Ehrin Armstrong

September 26, 2019

Presentation TCT 2019

There Are No Circumstances in Which I Have to Use DCB/DES

Presenter: Konstantinos Katsanos

September 26, 2019

Presentation TCT 2019

Deciphering the FDA Guidance

Presenter: Mehdi Shishehbor

September 26, 2019

Presentation TCT 2019

Long Segment SFA CTO in a Claudicant

Presenter: Brian DeRubertis

September 26, 2019

Presentation TCT 2019

State of the Art Lecture: Novel Drug Delivery Technologies for the SFA

Presenter: Juan Granada

September 26, 2019

Presentation TCT 2019

Introduction and Session Objectives

Presenter: Sahil Parikh

September 26, 2019

Presentation TCT 2019

Case #3: Transcatheter Tricuspid Therapy for Severe TR

Presenter: Christine Chung

September 25, 2019

Presentation TCT 2019

Case #2: Mitral Valve-in-MAC

Presenter: Stephanie El-Hajj

September 25, 2019

Advertisement

Portico Noninferior to Commercial TAVR Valves in IDE Study

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

TCT 2019 Day Two: Transcatheter Valves, New and Old

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

The Future in Managing Patients at High Bleeding Risk

Two Case Presentations Highlighting Relevant Patients

Onyx One: Results and Implications

Why Onyx One?

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

Who is the High Bleeding Risk Patient?

Emerging Drug-Free Platforms for the SFA: Can We Do Better Off Drugs?

Circumstances in Which I Feel That I Have to Use DCB/DES

There Are No Circumstances in Which I Have to Use DCB/DES

Deciphering the FDA Guidance

Long Segment SFA CTO in a Claudicant

State of the Art Lecture: Novel Drug Delivery Technologies for the SFA

Introduction and Session Objectives

Case #3: Transcatheter Tricuspid Therapy for Severe TR

Case #2: Mitral Valve-in-MAC

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content